Inogen (INGN)
(Real Time Quote from BATS)
$8.53 USD
+0.21 (2.52%)
Updated Sep 18, 2025 10:38 AM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INGN 8.53 +0.21(2.52%)
Will INGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for INGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INGN
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Wall Street Analysts See a 35.64% Upside in Inogen (INGN): Can the Stock Really Move This High?
INGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Top Medical Instruments Stocks Defying Tariff Pressure With GenAI
Wall Street Analysts Think Inogen (INGN) Could Surge 49.25%: Read This Before Placing a Bet
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y
Other News for INGN
MACD Bearish Signal Line Cross appears for INGN after 2.12% move
Technical picture remains unchanged for INGN after it falls 0.7% on September 16
INGN forms NR7 on September 15
Doji - Bearish? appears for INGN after 0.23% move
INGN forms Upper Bollinger Band Walk on September 11